Rationale and Design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A Multicenter, Cluster-Randomized Trial of P2Y12 Receptor Inhibitor Copayment Reduction after Myocardial Infarction

Conclusion ARTEMIS will be the largest randomized assessment of a medication copayment reduction intervention on medication persistence, clinical outcomes, treatment selection, and cost of care after acute MI.
Source: American Heart Journal - Category: Cardiology Source Type: research